The Impact of Positive Peritoneal Cytology on the Survival of Endometrial Cancer Patients

<b>Background</b>: Since the revision of the FIGO staging of endometrial cancer in 2009, patients with positive peritoneal cytology are no longer upstaged to stage IIIA. However, several studies demonstrated poorer outcomes in patients with positive washings. We conducted a survival anal...

Full description

Saved in:
Bibliographic Details
Main Authors: Anže Feguš, Tea Sara Sagaj, Nina Fokter Dovnik, Maja Pakiž, Andraž Dovnik
Format: Article
Language:English
Published: MDPI AG 2024-09-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/14/19/2160
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850283812378902528
author Anže Feguš
Tea Sara Sagaj
Nina Fokter Dovnik
Maja Pakiž
Andraž Dovnik
author_facet Anže Feguš
Tea Sara Sagaj
Nina Fokter Dovnik
Maja Pakiž
Andraž Dovnik
author_sort Anže Feguš
collection DOAJ
description <b>Background</b>: Since the revision of the FIGO staging of endometrial cancer in 2009, patients with positive peritoneal cytology are no longer upstaged to stage IIIA. However, several studies demonstrated poorer outcomes in patients with positive washings. We conducted a survival analysis with the aim of evaluating the impact of positive peritoneal cytology on the survival of EC patients. <b>Methods</b>: We performed a retrospective analysis of prospectively collected data on patients with endometrial cancer operated in our institution between 2008 and 2014. We analysed the impact of positive peritoneal cytology and other established prognostic factors on survival. <b>Results</b>: A total of 227 patients with a median follow-up of 6.9 years were included in the study. A total of 12.8% had positive peritoneal cytology. Positive peritoneal cytology was significantly associated with worse overall survival (HR 1.82; 95% CI 1.02–3.26; <i>p</i> 0.043) but not with worse recurrence-free survival (HR 1.64; 95% CI 0.92–2.93; <i>p</i> 0.091) in univariate analyses. In addition, tumour stage, histologic subtype, lymphovascular space invasion, grade, and the depth of myometrial invasion were all significant prognostic factors for overall survival in univariate analyses. In multivariate survival analysis, only the histologic subtype, tumour stage, and myometrial invasion remained in the model at the last step. <b>Conclusions</b>: Positive peritoneal cytology was associated with worse overall survival in our series of endometrial cancer patients. However, other traditional prognostic factors had a more important prognostic role for survival in a multivariate model.
format Article
id doaj-art-4b0a005d41d146e4b734b33671fa4b31
institution OA Journals
issn 2075-4418
language English
publishDate 2024-09-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj-art-4b0a005d41d146e4b734b33671fa4b312025-08-20T01:47:42ZengMDPI AGDiagnostics2075-44182024-09-011419216010.3390/diagnostics14192160The Impact of Positive Peritoneal Cytology on the Survival of Endometrial Cancer PatientsAnže Feguš0Tea Sara Sagaj1Nina Fokter Dovnik2Maja Pakiž3Andraž Dovnik4Medical Faculty, University of Maribor, Taborska 8, 2000 Maribor, SloveniaMedical Faculty, University of Maribor, Taborska 8, 2000 Maribor, SloveniaDepartment of Oncology, University Medical Centre Maribor, Ljubljanska 5, 2000 Maribor, SloveniaUniversity Clinic for Gynaecology and Obstetrics, University Medical Centre Maribor, Ljubljanska 5, 2000 Maribor, SloveniaMedical Faculty, University of Maribor, Taborska 8, 2000 Maribor, Slovenia<b>Background</b>: Since the revision of the FIGO staging of endometrial cancer in 2009, patients with positive peritoneal cytology are no longer upstaged to stage IIIA. However, several studies demonstrated poorer outcomes in patients with positive washings. We conducted a survival analysis with the aim of evaluating the impact of positive peritoneal cytology on the survival of EC patients. <b>Methods</b>: We performed a retrospective analysis of prospectively collected data on patients with endometrial cancer operated in our institution between 2008 and 2014. We analysed the impact of positive peritoneal cytology and other established prognostic factors on survival. <b>Results</b>: A total of 227 patients with a median follow-up of 6.9 years were included in the study. A total of 12.8% had positive peritoneal cytology. Positive peritoneal cytology was significantly associated with worse overall survival (HR 1.82; 95% CI 1.02–3.26; <i>p</i> 0.043) but not with worse recurrence-free survival (HR 1.64; 95% CI 0.92–2.93; <i>p</i> 0.091) in univariate analyses. In addition, tumour stage, histologic subtype, lymphovascular space invasion, grade, and the depth of myometrial invasion were all significant prognostic factors for overall survival in univariate analyses. In multivariate survival analysis, only the histologic subtype, tumour stage, and myometrial invasion remained in the model at the last step. <b>Conclusions</b>: Positive peritoneal cytology was associated with worse overall survival in our series of endometrial cancer patients. However, other traditional prognostic factors had a more important prognostic role for survival in a multivariate model.https://www.mdpi.com/2075-4418/14/19/2160endometrial cancerperitoneal cytologysurvivalprognostic factors
spellingShingle Anže Feguš
Tea Sara Sagaj
Nina Fokter Dovnik
Maja Pakiž
Andraž Dovnik
The Impact of Positive Peritoneal Cytology on the Survival of Endometrial Cancer Patients
Diagnostics
endometrial cancer
peritoneal cytology
survival
prognostic factors
title The Impact of Positive Peritoneal Cytology on the Survival of Endometrial Cancer Patients
title_full The Impact of Positive Peritoneal Cytology on the Survival of Endometrial Cancer Patients
title_fullStr The Impact of Positive Peritoneal Cytology on the Survival of Endometrial Cancer Patients
title_full_unstemmed The Impact of Positive Peritoneal Cytology on the Survival of Endometrial Cancer Patients
title_short The Impact of Positive Peritoneal Cytology on the Survival of Endometrial Cancer Patients
title_sort impact of positive peritoneal cytology on the survival of endometrial cancer patients
topic endometrial cancer
peritoneal cytology
survival
prognostic factors
url https://www.mdpi.com/2075-4418/14/19/2160
work_keys_str_mv AT anzefegus theimpactofpositiveperitonealcytologyonthesurvivalofendometrialcancerpatients
AT teasarasagaj theimpactofpositiveperitonealcytologyonthesurvivalofendometrialcancerpatients
AT ninafokterdovnik theimpactofpositiveperitonealcytologyonthesurvivalofendometrialcancerpatients
AT majapakiz theimpactofpositiveperitonealcytologyonthesurvivalofendometrialcancerpatients
AT andrazdovnik theimpactofpositiveperitonealcytologyonthesurvivalofendometrialcancerpatients
AT anzefegus impactofpositiveperitonealcytologyonthesurvivalofendometrialcancerpatients
AT teasarasagaj impactofpositiveperitonealcytologyonthesurvivalofendometrialcancerpatients
AT ninafokterdovnik impactofpositiveperitonealcytologyonthesurvivalofendometrialcancerpatients
AT majapakiz impactofpositiveperitonealcytologyonthesurvivalofendometrialcancerpatients
AT andrazdovnik impactofpositiveperitonealcytologyonthesurvivalofendometrialcancerpatients